Browse Category

NASDAQ:VTYX News 7 January 2026

Ventyx stock jumps on Lilly’s $1.2 billion buyout — and why it’s still trading under $14

Ventyx stock jumps on Lilly’s $1.2 billion buyout — and why it’s still trading under $14

New York, Jan 7, 2026, 17:32 EST — After-hours Shares of Ventyx Biosciences (VTYX.O) jumped on Wednesday after Eli Lilly (LLY.N) agreed to buy the San Diego-based biotech in a $14-per-share all-cash deal. Ventyx closed up about 37% at $13.81 and was last at $13.73 in after-hours trading, still shy of the offer price. Yahoo Finance For Lilly, the deal…
Ventyx Biosciences stock jumps premarket as Eli Lilly buyout talks fuel takeover buzz

Ventyx Biosciences stock jumps premarket as Eli Lilly buyout talks fuel takeover buzz

New York, Jan 7, 2026, 05:03 EST — Premarket Ventyx Biosciences shares jumped about 66% before the bell on Wednesday after a report that Eli Lilly is in advanced talks to buy the biotech company for more than $1 billion. The stock traded at $16.70 in premarket action, versus a $10.05 regular-session close. Public The move matters because a confirmed…

Stock Market Today

  • Ubisoft Share Price Drops 34% After Major Restructuring and Studio Closures
    January 25, 2026, 1:12 PM EST. Ubisoft's share price plunged 34%, hitting a 15-year low after announcing a "reset" plan involving the closure of two studios and cancellation of six games, including the delayed Prince of Persia remake. The publisher also delayed seven games to meet quality standards, likely affecting the rumored Assassin's Creed Black Flag remake. Facing a tougher AAA market and intense competition in shooter games, Ubisoft revised its full-year net bookings forecast down by €330 million to around €1.5 billion. The restructuring creates five specialized creative houses to focus on key franchises such as Assassin's Creed, Far Cry, and Rainbow Six. The turmoil follows leadership issues, including a lawsuit by former Assassin's Creed leader Marc-Alexis Côté.
Go toTop